Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 13, Issue 18
15 September 2007
Clinical Cancer Research Cover Image for Volume 13, Issue 18
All Issues
  • Cover Image

    Cover Image

    Issue cover image
    Reactive oxygen species (ROS) are key mediators of apoptosis induced by a polyphenol, (-)-epigallocatechin-3-gallate (EGCG), in myeloperoxidase (MPO)-positive leukemic cells. Highly toxic ROS, such as hydroxyl radical generated via H2O2/MPO/halide system, induce apoptosis and may directly mediate EGCG-induced apoptosis in HL-60 cells. To selectively detect the highly toxic ROS, leukemic cells were loaded with aminophenyl fluorescein (APF), and fluorescence-intensity images were acquired using an LSM510 confocal laser scanning unit. The fluorescence intensity of APF-loaded HL-60 cells greatly increased on stimulation with EGCG. For further details, please see Nakazato et al. on page 5436 in this issue.
  • PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265

Editorial

Ontology, Oncology, and Preventive Economies: Developing Drugs for Cancer Prevention
Victor G. Vogel
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

The Biology Behind

Progressive Thoughts about Progressive Disease
Neil P. Shah
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

CCR Practice of Translational Oncology

Targeted Agents: The Rules of Combination
Eunice L. Kwak; Jeffrey W. Clark; Bruce Chabner
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Molecular Pathways

Cytotoxic T-Lymphocyte–Associated Antigen-4
F. Stephen Hodi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy
James E. Talmadge
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

CCR Focus

From the Editor
Susan E. Bates
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Less Yin, More Yang: Confronting the Barriers to Cancer Immunotherapy
Gregory Lizée; Mayra A. Cantu; Patrick Hwu
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
Thomas F. Gajewski
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
Stephen H. Wrzesinski; Yisong Y. Wan; Richard A. Flavell
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
Xingxing Zang; James P. Allison
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Toll-like Receptors in Tumor Immunotherapy
Chrystal M. Paulos; Andrew Kaiser; Claudia Wrzesinski; Christian S. Hinrichs; Lydie Cassard; Andrea Boni; Pawel Muranski; Luis Sanchez-Perez; Douglas C. Palmer; Zhiya Yu; Paul A. Antony; Luca Gattinoni; Steven A. Rosenberg; Nicholas P. Restifo
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Report from the FDA

Bortezomib for the Treatment of Mantle Cell Lymphoma
Robert C. Kane; Ramzi Dagher; Ann Farrell; Chia-Wen Ko; Rajeshwari Sridhara; Robert Justice; Richard Pazdur
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Human Cancer Biology

ATM, CTLA4, MNDA, and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia
Avadhut D. Joshi; Ganapati V. Hegde; John D. Dickinson; Amit K. Mittal; James C. Lynch; James D. Eudy; James O. Armitage; Philip J. Bierman; R. Gregory Bociek; Marcel P. Devetten; Julie M. Vose; Shantaram S. Joshi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus
Katerina Dvorak; Melissa Chavarria; Claire M. Payne; Lois Ramsey; Cara Crowley-Weber; Barbora Dvorakova; Bohuslav Dvorak; Harris Bernstein; Hana Holubec; Richard E. Sampliner; Carol Bernstein; Anil Prasad; Sylvan B. Green; Harinder Garewal
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer
Lin Zhang; Jia Huang; Nuo Yang; Joel Greshock; Shun Liang; Kosei Hasegawa; Antonis Giannakakis; Nikolaos Poulos; Ann O'Brien-Jenkins; Dionyssios Katsaros; Ralf Butzow; Barbara L. Weber; George Coukos
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Serpin Peptidase Inhibitor Clade A Member 1 as a Potential Marker for Malignancy in Insulinomas
Sandra Valéria de Sá; Maria Lúcia Corrêa-Giannella; Márcio Carlos Machado; Karin Krogh; Madson Queiroz de Almeida; Maria Adelaide Albergaria Pereira; Sheila Aparecida Coelho Siqueira; Rosely Antunes Patzina; Felícia Satie Ibuki; Mari Cleide Sogayar; Marcel Cerqueira César Machado; Daniel Giannella-Neto
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats
Valérie Haydont; Céline Bourgier; Marc Pocard; Antoine Lusinchi; Jocelyne Aigueperse; Denis Mathé; Jean Bourhis; Marie-Catherine Vozenin-Brotons
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Platelets Take Up the Monoclonal Antibody Bevacizumab
Henk M.W. Verheul; Martijn P.J. Lolkema; David Z. Qian; Yvonne H.A. Hilkes; Eleni Liapi; Jan-Willem N. Akkerman; Roberto Pili; Emile E. Voest
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Imaging, Diagnosis, Prognosis

Polyclonal Immunoglobulin E Levels Are Correlated with Hemoglobin Values and Overall Survival in Patients with Multiple Myeloma
Giorgia Maria Elena Matta; Silvano Battaglio; Cristiana DiBello; Patrizia Napoli; Cristina Baldi; Giovannino Ciccone; Marta Coscia; Mario Boccadoro; Massimo Massaia
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Comparison of Gene Sets for Expression Profiling: Prediction of Metastasis from Low-Malignant Breast Cancer
Mads Thomassen; Qihua Tan; Freyja Eiriksdottir; Martin Bak; Søren Cold; Torben A. Kruse
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy
Patrick J. Bastian; Ganesh S. Palapattu; Srinivasan Yegnasubramanian; Xiaohui Lin; Craig G. Rogers; Leslie A. Mangold; Bruce Trock; Mario Eisenberger; Alan W. Partin; William G. Nelson
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
Ray-Hwang Yuan; Yung-Ming Jeng; Hung-Wei Pan; Fu-Chang Hu; Po-Lin Lai; Po-Huang Lee; Hey-Chi Hsu
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer
Shahrokh F. Shariat; Karim Bensalah; Jose A. Karam; Claus G. Roehrborn; Andrea Gallina; Yair Lotan; Kevin M. Slawin; Pierre I. Karakiewicz
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib
Toshimi Takano; Yuichiro Ohe; Koji Tsuta; Tomoya Fukui; Hiromi Sakamoto; Teruhiko Yoshida; Ukihide Tateishi; Hiroshi Nokihara; Noboru Yamamoto; Ikuo Sekine; Hideo Kunitoh; Yoshihiro Matsuno; Koh Furuta; Tomohide Tamura
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Increased Sentinel Lymph Node Lymphangiogenesis is Associated with Nonsentinel Axillary Lymph Node Involvement in Breast Cancer Patients with a Positive Sentinel Node
Gert G. Van den Eynden; Melanie K. Vandenberghe; Pieter-Jan H. van Dam; Cecile G. Colpaert; Peter van Dam; Luc Y. Dirix; Peter B. Vermeulen; Eric A. Van Marck
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Cancer Therapy: Clinical

Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors
Jayesh Desai; Sridhar Shankar; Michael C. Heinrich; Jonathan A. Fletcher; Christopher D. Fletcher; Judi Manola; Jeffrey A. Morgan; Christopher L. Corless; Suzanne George; Kemal Tuncali; Stuart G. Silverman; Annick D. Van den Abbeele; Eric van Sonnenberg; George D. Demetri
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid
Janet E. Brown; Susan P. Ellis; James E. Lester; Sandra Gutcher; Tina Khanna; Om-Prakesh Purohit; Eugene McCloskey; Robert E. Coleman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies
Shivaani Kummar; Martin Gutierrez; Erin R. Gardner; Erin Donovan; Kyunghwa Hwang; Eun Joo Chung; Min-Jung Lee; Kim Maynard; Mikhail Kalnitskiy; Alice Chen; Giovanni Melillo; Qin C. Ryan; Barbara Conley; William D. Figg; Jane B. Trepel; James Zwiebel; James H. Doroshow; Anthony J. Murgo
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Cancer Therapy: Preclinical

Targeting Methylguanine-DNA Methyltransferase in the Treatment of Neuroblastoma
Lars M. Wagner; Roger E. McLendon; K. Jin Yoon; Brian D. Weiss; Catherine A. Billups; Mary K. Danks
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts
Renier J. Brentjens; Elmer Santos; Yan Nikhamin; Raymond Yeh; Maiko Matsushita; Krista La Perle; Alfonso Quintás-Cardama; Steven M. Larson; Michel Sadelain
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Myeloperoxidase Is a Key Regulator of Oxidative Stress–Mediated Apoptosis in Myeloid Leukemic Cells
Tomonori Nakazato; Morihiko Sagawa; Kenji Yamato; Mingji Xian; Takehiro Yamamoto; Makoto Suematsu; Yasuo Ikeda; Masahiro Kizaki
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Preclinical Analysis of Tasidotin HCl in Ewing's Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma, and Osteosarcoma
Vaani Garg; Wendong Zhang; Pooja Gidwani; Mimi Kim; E. Anders Kolb
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth
Hua Zhong; Baohui Han; Irina L. Tourkova; Anna Lokshin; Alan Rosenbloom; Michael R. Shurin; Galina V. Shurin
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy
Xiong Li; You-Hong Liu; Yan-Ping Zhang; Shaobo Zhang; Xinzhu Pu; Thomas A. Gardner; Meei-Huey Jeng; Chinghai Kao
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Cancer Susceptibility and Prevention

Multiplicity of Benign Breast Lesions Is a Risk Factor for Progression to Breast Cancer
Maria J. Worsham; Usha Raju; Mei Lu; Alissa Kapke; Jingfang Cheng; Sandra R. Wolman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice
Xi Zheng; Xiao-Xing Cui; Gina E. Avila; Mou-Tuan Huang; Yue Liu; Jagruti Patel; Ah Ng Tony Kong; Raphael Paulino; Weichung Joe Shih; Yong Lin; Arnold B. Rabson; Bandaru S. Reddy; Allan H. Conney
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Short-term Modulation of Cell Proliferation and Apoptosis and Preventive/Therapeutic Efficacy of Various Agents in a Mammary Cancer Model
Konstantin Christov; Clinton J. Grubbs; Anne Shilkaitis; M. Margaret Juliana; Ronald A. Lubet
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Letter to the Editor

Interleukin-2 and Lymphokine-Activated Killer Cell Therapy in Patients with Relapsed B-Cell Lymphoma Treated with Rituximab
Vincenzo Pitini; Carmela Arrigo; Claudia Naro; Giuseppe Altavilla
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Cancer Therapy with Antibodies and Immunoconjugates

Introduction to the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates
David M. Goldenberg
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Cell Cycle Disturbances and Mitotic Catastrophes in HeLa Hep2 Cells following 2.5 to 10 Gy of Ionizing Radiation
David Eriksson; Per-Olov Löfroth; Lennart Johansson; Katrine Åhlström Riklund; Torgny Stigbrand
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The La Autoantigen Is a Malignancy-Associated Cell Death Target That Is Induced by DNA-Damaging Drugs
Fares Al-Ejeh; Jocelyn M. Darby; Michael P. Brown
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
In vivo Targeting of Dead Tumor Cells in a Murine Tumor Model Using a Monoclonal Antibody Specific for the La Autoantigen
Fares Al-Ejeh; Jocelyn M. Darby; Katherine Pensa; Kerrilyn R. Diener; John D. Hayball; Michael P. Brown
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Bortezomib Sensitizes Non–Hodgkin's Lymphoma Cells to Apoptosis Induced by Antibodies to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) Receptors TRAIL-R1 and TRAIL-R2
Mitchell R. Smith; Fang Jin; Indira Joshi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer
Leo Christopher DeRosier; Donald J. Buchsbaum; Patsy G. Oliver; Zhi-Qiang Huang; Jeffrey C. Sellers; William E. Grizzle; Wenquan Wang; Tong Zhou; Kurt R. Zinn; Joshua W. Long; Selwyn M. Vickers
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Review: Monoclonal Antibodies to the Vascular Endothelial Growth Factor Receptor-2 in Cancer Therapy
Hagop Youssoufian; Daniel J. Hicklin; Eric K. Rowinsky
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor
Eric K. Rowinsky; Hagop Youssoufian; James R. Tonra; Phillip Solomon; Douglas Burtrum; Dale L. Ludwig
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
Rhona Stein; M. Jules Mattes; Thomas M. Cardillo; Hans J. Hansen; Chien-Hsing Chang; Jack Burton; Serengulam Govindan; David M. Goldenberg
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies
Pierre-Yves Brard; Habibe Karacay; Rhona Stein; Robert M. Sharkey; M. Jules Mattes; Chien-Hsing Chang; Edmund A. Rossi; William J. McBride; David M. Goldenberg
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Improved Tumor Targeting and Decreased Normal Tissue Accumulation through Extracorporeal Affinity Adsorption in a Two-Step Pretargeting Strategy
Linda Mårtensson; Rune Nilsson; Tomas Ohlsson; Hans-Olov Sjögren; Sven-Erik Strand; Jan Tennvall
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Bispecific Antibody Pretargeting of Radionuclides for Immuno–Single-Photon Emission Computed Tomography and Immuno–Positron Emission Tomography Molecular Imaging: An Update
Robert M. Sharkey; Habibe Karacay; William J. McBride; Edmund A. Rossi; Chien-Hsing Chang; David M. Goldenberg
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The Dock and Lock Method: A Novel Platform Technology for Building Multivalent, Multifunctional Structures of Defined Composition with Retained Bioactivity
Chien-Hsing Chang; Edmund A. Rossi; David M. Goldenberg
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging
A. Sézeur; F.P. Châtelet; Ch. Cywiner; Cl. de Labriolle-Vaylet; C. Chastang; Cl. Billotey; M. Malafosse; D. Gallot; P. Betton; F. Montravers; S. Carvajal-Gonzalez; S. Askienazy; J.N. Talbot; J.D. Rain; G. Milhaud; G. Saumon; J. Barbet; A. Gruaz-Guyon
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Pretargeted Radioimmunotherapy for B-Cell Lymphomas
Damian J. Green; John M. Pagel; Anastasia Pantelias; Nathan Hedin; Yukang Lin; D. Scott Wilbur; Ajay Gopal; Donald K. Hamlin; Oliver W. Press
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Radioimmunotherapy with α-Particle–Emitting 213Bi-C-Functionalized trans-Cyclohexyl-Diethylenetriaminepentaacetic Acid-Humanized 3S193 Is Enhanced by Combination with Paclitaxel Chemotherapy
Marcus P. Kelly; Fook T. Lee; Kiki Tahtis; Fiona E. Smyth; Martin W. Brechbiel; Andrew M. Scott
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen
Nidia Alvarez-Rueda; Stéphanie Leprieur; Béatrice Clémenceau; Stéphane Supiot; Véronique Sébille-Rivain; Alain Faivre-Chauvet; François Davodeau; François Paris; Jacques Barbet; Jacques Aubry; Stéphane Birklé
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia
Rod Balhorn; Saphon Hok; Patricia A. Burke; Felice C. Lightstone; Monique Cosman; Adam Zemla; Gary Mirick; Julie Perkins; Arutselvan Natarajan; Michele Corzett; Sally J. DeNardo; Huguette Albrecht; Jeff P. Gregg; Gerry L. DeNardo
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Comparative Evaluation of Capsular Polysaccharide-Specific IgM and IgG Antibodies and F(ab′)2 and Fab Fragments as Delivery Vehicles for Radioimmunotherapy of Fungal Infection
Ekaterina Dadachova; Ruth A. Bryan; Xianchun Huang; Geraldina Ortiz; Tiffany Moadel; Arturo Casadevall
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Phase I to III Trials of Anti–B Cell Therapy in Non–Hodgkin's Lymphoma
Peter Martin; Richard R. Furman; Morton Coleman; John P. Leonard
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer
Ruby F. Meredith; Donald J. Buchsbaum; Ronald D. Alvarez; Albert F. LoBuglio
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Intraoperative Avidination for Radionuclide Therapy: A Prospective New Development to Accelerate Radiotherapy in Breast Cancer
Giovanni Paganelli; Mahila Ferrari; Laura Ravasi; Marta Cremonesi; Concetta De Cicco; Viviana Galimberti; Gregory Sivolapenko; Alberto Luini; Rita De Santis; Laura Lavinia Travaini; Maurizio Fiorenza; Marco Chinol; Stefano Papi; Claudio Zanna; Paolo Carminati; Umberto Veronesi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
A Phase I Study of 90Yttrium-Ibritumomab-Tiuxetan in Children and Adolescents with Relapsed/Refractory CD20-Positive Non–Hodgkin's Lymphoma: A Children's Oncology Group Study
Erin Cooney-Qualter; Mark Krailo; Anne Angiolillo; Rashid A. Fawwaz; Gregory Wiseman; Lauren Harrison; Virginia Kohl; Peter C. Adamson; Janet Ayello; Carmella vande Ven; Sherrie L. Perkins; Mitchell S. Cairo
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
New Ovarian Cancer Combo Shows Wider Promise
“Brain Fog” after CAR T May Be Reversible
Expanding the Targeted Protein Degradation Arsenal
View more recent articles
Breaking
Genentech, Orionis to Stick Together with Deal on Glues
Pfizer Shells Out up to $6 Billion for Bispecific Antibody
23andMe Acquired for Fraction of One-Time Value
View more recent articles
Research Watch
Common Blood Tests Predict CAR T-cell Therapy Response in Non-Hodgkin Lymphoma
Frequent Blood Donation Influences DNMT3A-Driven Clonal Hematopoiesis
A Single-Cell Atlas Reveals Characteristics of Pan-Cancer Brain Metastases
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept